Thyroid function in children with epilepsy treated with sodium valproate monotherapy: A prospective study

Clinical Neuropharmacology

Volumn 32, Issue 1, 2009, Pages 32-34

  Attilakos, Achilleas ^a,c   Katsarou, Eustathia ^b   Prassouli, Alexia ^b   Mastroyianni, Sotiria ^b   Voudris, Konstantinos ^b   Fotinou, Aspasia ^b   Garoufi, Anastasia ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b Children's Hospital Athens   (Greece)

^c NONE   (Greece)

Author keywords

Children; Epilepsy (Clin Neuropharm 2009; 32: 32Y34); Sodium valproate monotherapy; Thyroid

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE; VALPROIC ACID;

ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; MONOTHERAPY; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 67749111759     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e318166cbcd     Document Type: Article

References (11)

1. Isojarvi JI, Turkka J, Pakarinen AJ, et al. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001;42:930-934.
2. Verrotti A, Basciani F, Morresi S, et al. Thyroid hormones in epileptic children receiving carbamazepine and valproic acid. Pediatr Neurol 2001;25:43-46.
3. Eiris-Punal J, Del Rio-Garma M, Del Rio-Garma MC, et al. Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism. Epilepsia 1999;40:1761-1766.
4. Isojarvi JIT, Pakarinen AJ, Ylipalosaari PJ, et al. Serum hormones in male patients with epilepsy patients receiving anticonvulsant medication. Arch Neurol 1990;47:670-676.
5. Isojarvi JI, Pakarinen AJ, Myllyla VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33:142-144.
6. Vainionpaa LK, Mikkonen K, Rattya J, et al. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication. Epilepsia 2004;45:197-203.
7. Mikati MA, Tarabay H, Khalil A, et al. Risk factors for development of subclinical hypothyroidism during valproic acid therapy. J Pediatr 2007;151:178-181.
8. Cansu A, Serdaroǧlu A, Camurdan O, et al. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Epilepsia 2006;47:1855-1859.
9. Loscher W, Schmidt D. Increase of human plasma GABA by sodium valproate. Epilepsia 1980;21:611-615.
10. Graf WD, Oleinik OE, Glauser TA, et al. Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy. Neuropediatrics 1998;29:195-201.
11. Pizzulli A, Ranjbar A. Selenium deficiency and hypothyroidism: a new etiology in the differential diagnosis of hypothyroidism in children. Biol Trace Elem Res 2000;77:199-208.